Back to trial detailsIntake questionnaire
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
Applying to H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida
Answer a few short questions to share with the research team.
0 of 3 answered